Zobrazeno 1 - 9
of 9
pro vyhledávání: '"масталгія"'
Publikováno v:
Репродуктивне здоров'я жінки; № 9-10 (2021); 48-60
Reproductive health of woman; № 9-10 (2021); 48-60
Reproductive health of woman; No. 9-10 (2021); 48-60
Репродуктивне здоров'я жінки; № 3 (2021); 21-33
Reproductive health of woman; № 3 (2021); 21-33
Reproductive health of woman; No. 3 (2021); 21-33
Репродуктивная эндокринология, Vol 0, Iss 50, Pp 76-88 (2019)
Reproductive health of woman; № 9-10 (2021); 48-60
Reproductive health of woman; No. 9-10 (2021); 48-60
Репродуктивне здоров'я жінки; № 3 (2021); 21-33
Reproductive health of woman; № 3 (2021); 21-33
Reproductive health of woman; No. 3 (2021); 21-33
Репродуктивная эндокринология, Vol 0, Iss 50, Pp 76-88 (2019)
Background. Cyclic mastalgia (CM) is premenstrual bilateral and diffuse breast pain that presents cyclically and affects women in their reproductive years. It may associate with latent hyperprolactinemia due to the insufficient inhibitory effect of d
Publikováno v:
Reproductive Endocrinology; No. 57 (2021); 48-53
Репродуктивная эндокринология; № 57 (2021); 48-53
Репродуктивна ендокринологія; № 57 (2021); 48-53
Репродуктивная эндокринология; № 57 (2021); 48-53
Репродуктивна ендокринологія; № 57 (2021); 48-53
In the twentieth century, a whole teaching of mastopathy was formed. However, over time, accumulated data have questioned the existence of mastopathy as a separate nosological form, because the term “fibrocystic disease” while mastalgia is the mo
Publikováno v:
Reproductive Endocrinology; No. 58 (2021); 79-82
Репродуктивная эндокринология; № 58 (2021); 79-82
Репродуктивна ендокринологія; № 58 (2021); 79-82
Репродуктивная эндокринология; № 58 (2021); 79-82
Репродуктивна ендокринологія; № 58 (2021); 79-82
Cyclic mastalgia of varying intensity occurs every month in at least 70% of women, persistent pain in the mammary glands of moderate and severe degree is occur in about 50% of patients with benign mastopathy. The cause of mastodynia is the morphofunc
Publikováno v:
Репродуктивне здоров'я жінки; № 2 (2021); 53-56
Reproductive health of woman; № 2 (2021); 53-56
Reproductive health of woman; No. 2 (2021); 53-56
Reproductive health of woman; № 2 (2021); 53-56
Reproductive health of woman; No. 2 (2021); 53-56
The purpose of the study wasto examine the effectiveness of the drug Mastodynon® for the treatment of mastopathy in pre- and perimenopausal women.Materials and methods. The research was carried out within 12 months. Patient presenting complaints of
Publikováno v:
Reproductive Endocrinology; № 50 (2019); 76-88
Репродуктивная эндокринология; № 50 (2019); 76-88
Репродуктивна ендокринологія; № 50 (2019); 76-88
Репродуктивная эндокринология; № 50 (2019); 76-88
Репродуктивна ендокринологія; № 50 (2019); 76-88
Background: Cyclic mastalgia (CM) is premenstrual bilateral and diffuse breast pain that presents cyclically and affects women in their reproductive years. It may associate with latent hyperprolactinemia due to the insufficient inhibitory effect of d
Publikováno v:
Reproductive Endocrinology; № 48 (2019); 77-81
Репродуктивная эндокринология; № 48 (2019); 77-81
Репродуктивна ендокринологія; № 48 (2019); 77-81
Репродуктивная эндокринология; № 48 (2019); 77-81
Репродуктивна ендокринологія; № 48 (2019); 77-81
Implementation of breast cancer screening using digital mammography improved the diagnosis of primary proliferative regressive structural changes in the breast, manifested as diffuse or diffusely-nodal deformations of tissues. Currently, women are si
Publikováno v:
Репродуктивна ендокринологія; № 40 (2018); 93-97
Репродуктивная эндокринология; № 40 (2018); 93-97
Reproductive Endocrinology; № 40 (2018); 93-97
Репродуктивная эндокринология; № 40 (2018); 93-97
Reproductive Endocrinology; № 40 (2018); 93-97
Дисгормональные дисплазии молочных желез – самая частая патология, с которой встречаются практикующие врачи. Интерес клиницистов к да
Publikováno v:
Репродуктивна ендокринологія; № 38 (2017); 81-85
Репродуктивная эндокринология; № 38 (2017); 81-85
Reproductive Endocrinology; № 38 (2017); 81-85
Репродуктивная эндокринология; № 38 (2017); 81-85
Reproductive Endocrinology; № 38 (2017); 81-85
Objective. To evaluate the efficacy and tolerability of Mastodynon® in the treatment of diffuse mastopathy and symptoms of premenstrual syndrome (PMS) in women in the menopausaltransition period.Subjects and methods. A clinical prospective, parallel
Publikováno v:
Репродуктивна ендокринологія; № 17 (2014); 90-97
Репродуктивная эндокринология; № 17 (2014); 90-97
Reproductive Endocrinology; № 17 (2014); 90-97
Репродуктивная эндокринология; № 17 (2014); 90-97
Reproductive Endocrinology; № 17 (2014); 90-97
In recent decades it have seen a growth of benign breast disease, in particular fibrocystic breasts. Pain in breasts at mastopathia is the most important cause of women visits to the doctor. There are cyclic breast pain (2/3 cases) and non-cyclic (1/